BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 4, 2021
View Archived Issues
SSTR5 splice variant sst5TMD4 for diagnosis and prognosis of high-grade gliomas
Read More
Fecal microbiota transplantation used to create autism model in rat offspring
Read More
Bispecific antibody may allow safer targeting of the IL-2 signaling pathway
Read More
Corbus licenses integrin-targeting MAbs, CRB-601 and CRB-602
Read More
China's NMPA accepts IND application for CT-120, a dual-antigen specific CAR-T therapy
Read More
Oyster Point expands its pipeline and announces promising preclinical data
Read More
Hoth Therapeutics reports preclinical data for novel HT-KIT candidate
Read More
Monopar and the National University of Singapore collaborate on development of MNPR-202
Read More
Multi-characteristic opsin gene therapy restores clinically meaningful vision in patients with RP
Read More
Algernon launches new clinical research program for ifenprodil in pancreatic cancer
Read More
First patient dosed in phase I/II study of PhageBank in urinary tract infections
Read More
Histogen provides development and pipeline updates
Read More
Karolinska announces that Dilafor successfully concluded its phase IIb study of tafoxiparin
Read More
Betta Pharmaceuticals patents PI3K inhibitors
Read More
LG Chem discloses new melanocortin MC4 receptor agonists
Read More
Dermira synthesizes new MRGPRX2 antagonists
Read More
Hangzhou Hertz Pharmaceutical divulges PD-1/PD-L1 interaction inhibitors
Read More
University of California identifies ROR2-targeting antibodies for cancer
Read More
BI-655064 does not meet CRR primary endpoint in lupus nephritis phase II trial
Read More
Evaxion reports preclinical proof-of-concept data for its AI-powered RAVEN vaccine platform
Read More
Novartis initiates recruitment in phase I study of INE-963
Read More
PINK1 and Parkin stabilize mutations in mitochondrial DNA
Read More
INO-4700 MERS-CoV vaccine candidate enters phase II studies
Read More
Gilead Sciences initiates phase I study of KITE-222 autologous CAR-T cell therapy
Read More
KZR-616 is safe and well tolerated in patients with active SLE
Read More